Flow diagram for the identification of studies included. حسب Jin-Min Gu (17915039)

الموضوعات:

Forest plot of the hospital stay length in distinct stages of patients. حسب Jin-Min Gu (17915039)

الموضوعات:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. حسب Claire M. Douglas (21238238)

الموضوعات:

Participant demographic and clinical characteristics. حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... حسب Claire M. Douglas (21238238)

الموضوعات:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... حسب Claire M. Douglas (21238238)

الموضوعات:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... حسب Claire M. Douglas (21238238)

الموضوعات:

Schematic representation of the study protocol. حسب Neng Pan (5262032)

الموضوعات:

Baseline characteristics. حسب Neng Pan (5262032)

الموضوعات:

Comparison within groups. حسب Neng Pan (5262032)

الموضوعات:

Comparison before and after the experiment in each group. حسب Neng Pan (5262032)

الموضوعات:

Data ste. حسب Neng Pan (5262032)

الموضوعات:

Comparison of data after the experiment. حسب Neng Pan (5262032)

الموضوعات:

Correlation diagram of each parameter in each group. حسب Neng Pan (5262032)

الموضوعات:

Recruitment process. حسب Neng Pan (5262032)

الموضوعات:

Comparison of post-experimental outcome measures. حسب Neng Pan (5262032)

الموضوعات:

The table shows the significant and non-significant altered group with different parameters. حسب Ashraf Attia Mahmoud (21262201)

الموضوعات:

Most significant muscle activation values. حسب María Benito-de-Pedro (22057468)

الموضوعات: